To evoke a full- and adequate immunological reaction, vaccines include aluminum adjuvant in addition to virus-like particles as antigens. Chronic stimulation of the immune system by adjuvants can result in an autoimmune disease characterized by myalgia, arthralgia, chronic fatigue, and neurological manifestations – appropriately named the autoimmune/inflammatory syndrome induced by adjuvants (ASIA)7,8. According to the HPV vaccination, there are two recent well-documented review articles. Palmieri B. et al reported the occurrence of severe somatoform and dysautonomic syndromes after HPV vaccination9 and Brinth L. et al. also described the onset of autonomic dysfunction after the quadrivalent vaccination10. Both reviews clearly indicated the presence of unique adverse reactions associated with the HPV vaccination including headache, fatigue, depression, cognitive dysfunctions, uncontrollable and involuntary movement, and limb weakness. For these clinical manifestations, we have coined these reactions as human papillomavirus vaccination-associated neuro-immunopathic syndrome (HANS) and proposed diagnostic criteria. HANS syndrome is thought to consist of four clinical domains; (i) autonomic, endocrine and inflammatory symptoms; (ii) cognitive and emotional symptoms; (iii) environmental hypersensitivity and pain symptoms and (iv) locomotion and motor symptoms11,12. Several clinical studies on HANS symptoms have also shown that the HPV vaccines may influence the central nervous system (CNS)10,13,14,15.